We would love to hear your thoughts about our site and services, please take our survey here.

Less Ads, More Data, More Tools Register for FREE

AstraZeneca says to release 2 mln vaccine doses a week to UK by mid-Feb

Wed, 13th Jan 2021 11:01

LONDON, Jan 13 (Reuters) - AstraZeneca is scaling up
releases of COVID-19 vaccine doses to the United Kingdom to the
point where it expects to be providing 2 million a week by or
before the middle of February, a top executive told lawmakers on
Wednesday.

"We've released just over 1.1 million doses, to date, and we
are scaling up as we've said very rapidly. And this will happen
imminently, to releasing 2 million doses a week, we're
absolutely on track to do that," said Tom Keith-Roach, president
of AstraZeneca UK.

"We're scaling up to 2 million a week imminently, and
certainly we hope to be there on or before the middle of
February," he said.
(Reporting by Alistair Smout and Estelle Shirbon, Editing by
Paul Sandle)

Related Shares

More News
2 May 2024 10:04

AstraZeneca notes positive trial results for Calquence treatment

(Alliance News) - AstraZeneca PLC on Thursday said it observed positive high-level results in the Echo phase 3 trial of its Calquence treatment for pr...

2 May 2024 07:45

AstraZeneca reports positive results from blood cancer drug trial

(Sharecast News) - AstraZeneca has reported positive results from the use of its Calquence drug in a clinical trial to treat a rare type of blood canc...

29 Apr 2024 22:52

J&J, Bristol Myers lose challenges to US drug price negotiation program

April 29 (Reuters) - A U.S. judge on Monday rejected a challenge by Bristol Myers Squibb and Johnson & Johnson to a law requiring them to negoti...

29 Apr 2024 10:02

LONDON BROKER RATINGS: Deutsche Bank likes Frasers; Barclays cuts JD

(Alliance News) - The following London-listed shares received analyst recommendations Monday morning and Friday:

29 Apr 2024 09:13

AstraZeneca makes progress with Truqap and Enhertu cancer treatments

(Alliance News) - AstraZeneca PLC on Monday said its Truqap drug has been recommended for approval in the EU to treat a form of breast cancer, while a...

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.